Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 2
2018 10
2019 6
2020 11
2021 5
2022 7
2023 5
2024 8
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

48 results

Results by year

Filters applied: . Clear all
Page 1
Development of SGLT1 and SGLT2 inhibitors.
Rieg T, Vallon V. Rieg T, et al. Diabetologia. 2018 Oct;61(10):2079-2086. doi: 10.1007/s00125-018-4654-7. Epub 2018 Aug 22. Diabetologia. 2018. PMID: 30132033 Free PMC article. Review.
Metabolic Communication by SGLT2 Inhibition.
Billing AM, Kim YC, Gullaksen S, Schrage B, Raabe J, Hutzfeldt A, Demir F, Kovalenko E, Lassé M, Dugourd A, Fallegger R, Klampe B, Jaegers J, Li Q, Kravtsova O, Crespo-Masip M, Palermo A, Fenton RA, Hoxha E, Blankenberg S, Kirchhof P, Huber TB, Laugesen E, Zeller T, Chrysopoulou M, Saez-Rodriguez J, Magnussen C, Eschenhagen T, Staruschenko A, Siuzdak G, Poulsen PL, Schwab C, Cuello F, Vallon V, Rinschen MM. Billing AM, et al. Circulation. 2024 Mar 12;149(11):860-884. doi: 10.1161/CIRCULATIONAHA.123.065517. Epub 2023 Dec 28. Circulation. 2024. PMID: 38152989 Free PMC article.
Glycolytic lactate in diabetic kidney disease.
Darshi M, Kugathasan L, Maity S, Sridhar VS, Fernandez R, Limonte CP, Grajeda BI, Saliba A, Zhang G, Drel VR, Kim JJ, Montellano R, Tumova J, Montemayor D, Wang Z, Liu JJ, Wang J, Perkins BA, Lytvyn Y, Natarajan L, Lim SC, Feldman H, Toto R, Sedor JR, Patel J, Waikar SS, Brown J, Osman Y, He J, Chen J, Reeves WB, de Boer IH, Roy S, Vallon V, Hallan S, Gelfond JA, Cherney DZ, Sharma K; Kidney Precision Medicine Project, and the CRIC Study Investigators. Darshi M, et al. JCI Insight. 2024 Jun 10;9(11):e168825. doi: 10.1172/jci.insight.168825. JCI Insight. 2024. PMID: 38855868 Free PMC article.
Renoprotective Effects of SGLT2 Inhibitors.
Vallon V. Vallon V. Heart Fail Clin. 2022 Oct;18(4):539-549. doi: 10.1016/j.hfc.2022.03.005. Heart Fail Clin. 2022. PMID: 36216484 Free PMC article. Review.
SGLT2 inhibition and kidney protection.
Nespoux J, Vallon V. Nespoux J, et al. Clin Sci (Lond). 2018 Jun 28;132(12):1329-1339. doi: 10.1042/CS20171298. Print 2018 Jun 29. Clin Sci (Lond). 2018. PMID: 29954951 Free PMC article. Review.
48 results